Department of Food Science and Rutgers Center for Lipid Research, Rutgers University, New Brunswick, New Jersey 08901, USA.
J Biol Chem. 2012 Sep 28;287(40):33364-76. doi: 10.1074/jbc.M112.402339. Epub 2012 Aug 3.
Pah1p, which functions as phosphatidate phosphatase (PAP) in the yeast Saccharomyces cerevisiae, plays a crucial role in lipid homeostasis by controlling the relative proportions of its substrate phosphatidate and its product diacylglycerol. The diacylglycerol produced by PAP is used for the synthesis of triacylglycerol as well as for the synthesis of phospholipids via the Kennedy pathway. Pah1p is a highly phosphorylated protein in vivo and has been previously shown to be phosphorylated by the protein kinases Pho85p-Pho80p and Cdc28p-cyclin B. In this work, we showed that Pah1p was a bona fide substrate for protein kinase A, and we identified by mass spectrometry and mutagenesis that Ser-10, Ser-677, Ser-773, Ser-774, and Ser-788 were the target sites of phosphorylation. Protein kinase A-mediated phosphorylation of Pah1p inhibited its PAP activity by decreasing catalytic efficiency, and the inhibitory effect was primarily conferred by phosphorylation at Ser-10. Analysis of the S10A and S10D mutations (mimicking dephosphorylation and phosphorylation, respectively), alone or in combination with the seven alanine (7A) mutations of the sites phosphorylated by Pho85p-Pho80p and Cdc28p-cyclin B, indicated that phosphorylation at Ser-10 stabilized Pah1p abundance and inhibited its association with membranes, PAP activity, and triacylglycerol synthesis. The S10A mutation enhanced the physiological effects imparted by the 7A mutations, whereas the S10D mutations attenuated the effects of the 7A mutations. These data indicated that the protein kinase A-mediated phosphorylation of Ser-10 functions in conjunction with the phosphorylations mediated by Pho85p-Pho80p and Cdc28p-cyclin B and that phospho-Ser-10 should be dephosphorylated for proper PAP function.
Pah1p 在酵母酿酒酵母中作为磷酸二酯酶(PAP)发挥作用,通过控制其底物磷酸二酯酶和产物二酰基甘油的相对比例,在脂质动态平衡中发挥关键作用。PAP 产生的二酰基甘油用于三酰基甘油的合成以及通过 Kennedy 途径合成磷脂。Pah1p 在体内是一种高度磷酸化的蛋白质,先前已被证明可被蛋白激酶 Pho85p-Pho80p 和 Cdc28p-cyclin B 磷酸化。在这项工作中,我们表明 Pah1p 是蛋白激酶 A 的真正底物,并通过质谱分析和突变鉴定出 Ser-10、Ser-677、Ser-773、Ser-774 和 Ser-788 是磷酸化的靶位。蛋白激酶 A 介导的 Pah1p 磷酸化通过降低催化效率抑制其 PAP 活性,抑制作用主要由 Ser-10 的磷酸化赋予。单独或组合分析 S10A 和 S10D 突变(分别模拟去磷酸化和磷酸化)以及 Pho85p-Pho80p 和 Cdc28p-cyclin B 磷酸化的七个丙氨酸(7A)突变,表明 Ser-10 磷酸化稳定了 Pah1p 的丰度并抑制了其与膜的结合、PAP 活性和三酰基甘油合成。S10A 突变增强了 7A 突变赋予的生理效应,而 S10D 突变则减弱了 7A 突变的效应。这些数据表明,蛋白激酶 A 介导的 Ser-10 磷酸化与 Pho85p-Pho80p 和 Cdc28p-cyclin B 介导的磷酸化协同作用,并且磷酸化 Ser-10 应该去磷酸化以实现适当的 PAP 功能。